Watson

Is a Crisis Brewing for Watson Health?

Is a Crisis Brewing for Watson Health?

By

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Sunday at SXSW: Healthcare costs and cancer

Sunday at SXSW: Healthcare costs and cancer

By

A high-profile cancer track commands attention, while wearables and IBM Watson Health come under fire.

Five things for pharma marketers to know: Wednesday, February 22, 2017

Five things for pharma marketers to know: Wednesday, February 22, 2017

By

Audit says MD Anderson Cancer Center mismanaged Watson partnership; Icahn takes stake in BMS; Sarepta sells priority review voucher to Gilead

Why healthbots may eat search ads and mobile apps

Why healthbots may eat search ads and mobile apps

By

The internet strongly agrees there's an artificial intelligence revolution going on, and it's come to pharma marketing.

Five things for pharma marketers to know: Friday, December 2, 2016

Five things for pharma marketers to know: Friday, December 2, 2016

By

Regeneron and Pfizer CEOs argue about the industry's reputation; Mylan CEO defends the EpiPen; Pfizer and IBM to partner on cancer immunotherapies

Second-generation IBM star pushes for partnerships

Second-generation IBM star pushes for partnerships

By

With a lead role in IBM Watson's bold gambit to transform healthcare, Kathy McGroddy-Goetz ranks as one of the enterprise's most important individuals.

How IBM's Cognitive Computing Platform Might Help Make Healthcare Smarter

How IBM's Cognitive Computing Platform Might Help Make Healthcare Smarter

Soon, IBM says, Watson will be used by one particular pharma company to create a website where, once a drug is prescribed, patients can ask questions in their own words and the website will provide answers in near real-time.